dichlorphenamide — United Healthcare
primary hyperkalemic periodic paralysis or related variant
Initial criteria
- Diagnosis of primary hyperkalemic periodic paralysis or related variant OR Diagnosis of primary hypokalemic periodic paralysis or related variant
Reauthorization criteria
- Documentation of positive clinical response
Approval duration
12 months